NANO-PEFIS | A combined photoelectrochemical and fluorescence imaging system for investigating nanoparticle-cell interactions

Summary
Nanoparticles (NPs) have become increasingly attractive for biomedical applications such as targeted drug delivery, cancer therapy,
and bioimaging due to their excellent properties. The investigation of NP-cell interactions (cellular uptake and cytotoxicity) is crucial
to the development of safe and effective use of NP in living organisms. However, current methods for studying NP-cell interactions
rely on fluorescence microscopy, and complementary methods need to be done separately. Therefore, we propose to develop a novel
imaging system that can conduct label-free photoelectrochemical imaging and fluorescence imaging simultaneously so that electrical signals from the basal side of cells and fluorescence signals can be obtained in tandem. A laser with a suitable wavelength will be used as the excitation source for both fluorescence and photocurrent. This imaging system will be validated by monitoring cell viability with
fluorescence assay and photocurrent imaging, and by monitoring the cellular uptake of model NPs to correlate the physicochemical properties of NPs to their uptake efficiency and toxicity. These validation experiments will be compared with established techniques. This system will be used to study neuron-NP interactions to reveal the mechanism of NPs’ functional effects in neuronal activities. The combined imaging system will help us gain a deeper understanding of NP-cell interactions and will offer a label-free method for assessing the toxicity of NPs in the biomedicine field. Therefore, this project will facilitate the rapid development of safe and effective nanomedicines and nano-delivery systems that allow site-specific, target-oriented delivery of precise medicines to treat and prevent various diseases. This will significantly increase the impact of nanomedicines in the clinic, increase the quality of life for an ageing population and help us respond to public health emergencies effectively.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/101153876
Start date: 02-09-2024
End date: 01-09-2026
Total budget - Public funding: - 173 847,00 Euro
Cordis data

Original description

Nanoparticles (NPs) have become increasingly attractive for biomedical applications such as targeted drug delivery, cancer therapy,
and bioimaging due to their excellent properties. The investigation of NP-cell interactions (cellular uptake and cytotoxicity) is crucial
to the development of safe and effective use of NP in living organisms. However, current methods for studying NP-cell interactions
rely on fluorescence microscopy, and complementary methods need to be done separately. Therefore, we propose to develop a novel
imaging system that can conduct label-free photoelectrochemical imaging and fluorescence imaging simultaneously so that electrical signals from the basal side of cells and fluorescence signals can be obtained in tandem. A laser with a suitable wavelength will be used as the excitation source for both fluorescence and photocurrent. This imaging system will be validated by monitoring cell viability with
fluorescence assay and photocurrent imaging, and by monitoring the cellular uptake of model NPs to correlate the physicochemical properties of NPs to their uptake efficiency and toxicity. These validation experiments will be compared with established techniques. This system will be used to study neuron-NP interactions to reveal the mechanism of NPs’ functional effects in neuronal activities. The combined imaging system will help us gain a deeper understanding of NP-cell interactions and will offer a label-free method for assessing the toxicity of NPs in the biomedicine field. Therefore, this project will facilitate the rapid development of safe and effective nanomedicines and nano-delivery systems that allow site-specific, target-oriented delivery of precise medicines to treat and prevent various diseases. This will significantly increase the impact of nanomedicines in the clinic, increase the quality of life for an ageing population and help us respond to public health emergencies effectively.

Status

SIGNED

Call topic

HORIZON-MSCA-2023-PF-01-01

Update Date

29-09-2024
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon Europe
HORIZON.1 Excellent Science
HORIZON.1.2 Marie Skłodowska-Curie Actions (MSCA)
HORIZON.1.2.0 Cross-cutting call topics
HORIZON-MSCA-2023-PF-01
HORIZON-MSCA-2023-PF-01-01 MSCA Postdoctoral Fellowships 2023